When is the best time to archive the TMF?

Blog Tom Lynam

It’s a question we get asked a lot at Arkivum, and it’s rarely met with the same answer twice.

Some sponsors and CROs move their trial master file into a long-term archive the moment a study closes out. Others wait several years before making the move. And unfortunately, some at the moment don’t really archive, or preserve, at all.

As with many things in life, the honest answer to the question is “it depends.” There are several factors that shape when the right time to archive actually is, and I want to walk through each of them in this post.

The quick answer is that although there is no definitive best time to archive the TMF, there is a very strong case to be made to migrating all TMF records into a fit for purpose long-term digital archive as soon as possible after the trial has closed. I would also strongly recommend having a plan for how you are going to archive the TMF at the start of the study, and not wait until closeout approaches.

Let’s explore this in more detail in the rest of the post.

 

The longer data sits in a live system, the greater the risk

The first factor is data integrity. The longer records are held within their original, live system, the greater the risk that integrity issues will occur. If that system doesn’t have safeguarding or preservation capability built in, the risk only increases with time.

Live systems are built to support a trial while it’s running, not to guarantee the legibility and integrity of records for decades afterwards. Ultimately, how comfortable you are with this comes down to risk appetite. If you were inspected during that period, could you evidence how integrity has been maintained throughout the entire retention period? That’s the question worth sitting with.

 

Migration is unavoidable, so timing matters

The second consideration is the ease (or increased risk) of moving data further down the line. With the UK and EU CTR’s 25-year retention period, it’s extremely unlikely that records will remain in those live or source systems for the whole of that period.

At some point, they will need to be moved into a suitable archive. And this is arguably easier, and less risky, the closer it’s done to the end of the trial. The team involved is likely still the same people, and they’re familiar with the datasets, the systems and the stakeholders involved. That familiarity reduces the chance of mistakes, and makes any that do occur easier to resolve.

Again, there’s a level of risk appetite at play here. The longer records are left within a source system, the greater the risk that the people, technology and institutional knowledge needed for a smooth migration won’t be there when you finally need them.

 

Cost is easier to manage with a consolidated archive

The third factor is cost. In our experience, it’s much easier to manage the long-term cost of retention over the entire 25-year period with a single, consolidated archive than it is leaving data within one or many source systems.

This isn’t a guarantee that consolidation will save money. Every organisation’s situation is unique. But it’s a pattern we consistently see across our customer base, and it’s worth factoring into any business case for archiving sooner rather than later.

We recently a published a case study with LEO Pharma, who were able to realise ROI on their dedicated digital archive solution by decommissioning just two systems.

 

A well-ordered TMF makes M&A activity easier

The final consideration is one we see most often with smaller sponsors. Having a well-ordered and properly packaged TMF makes any future M&A activity considerably more straightforward. Due diligence and the transfer of assets are both much simpler when records are consolidated, healthy and readily accessible in one system, rather than scattered across multiple source systems in varying states of order.

For organisations that may be acquired, or that may be looking to acquire, this can end up being one of the more practical, commercially driven reasons to get long-term retention right early.

 

There’s no single right answer, but there is a case for not waiting

To finish, I think it’s important to say there is no definitive “right” time to archive the TMF. But I’d argue there is a strong case for not waiting too long.

What matters most, regardless of when you decide to make the move, is having a plan in place early. Don’t wait until study close-out to start thinking about it.

Long-term retention of the TMF and other essential records shouldn’t be an afterthought. It deserves the same level of planning and consideration as any other part of running a trial.

You can find out more about how to archive the TMF on our dedicated page, or if you’d like to discuss any of the points raised in this post, feel free to get in touch with me at Tom.Lynam@Arkivum.com.

Arkivum image

Tom Lynam

Tom is the Marketing Director at Arkivum. He joined the business in January 2020 tasked with driving new business growth and building the brand into new sectors such as Pharmaceutical and Life Sciences. He has over 12 years’ experience in several diverse marketing leadership roles across technology and professional services organisations.

Get in touch

Interested in finding out more? Click the link below to arrange a time with one of our experienced team members.

Book a demo

SHARE

Related resources

Interested in finding out more?

Message us via our contact us page or book some time in with one of our experienced team. We’ll arrange an initial exploratory discussion to better understand your requirements, and whether the Arkivum solution will help you solve your challenges.